Top compounds associated with response to JMJD1C


Feature Type Standardized
Nominal ANOVA
mRNA Nilotinib CCLE pan-cancer AAC 0.0002 1
mRNA carboplatin:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.00014 1
mRNA Methotrexate FIMM pan-cancer AAC -0.00053 1
mRNA cediranib CTRPv2 pan-cancer AAC 0.00017 1
mRNA Doxorubicin gCSI pan-cancer AAC -5.2e-05 1
mRNA ATRA FIMM pan-cancer AAC 1.5e-05 1
Download CSV